7 months ago
1
In a important boost to biomedical innovation successful Andhra Pradesh, Ipseity Diagnostics and Research, a U.S.-based molecular diagnostics company, has entered into a technological collaboration with Vignan’s Foundation for Science, Technology and Research. The concern aims to bring transcriptomics, low-cost PCR technologies, and Next Generation Sequencing (NGS) to the State, marking a large measurement toward strengthening precocious molecular probe capabilities.
The Memorandum of Understanding (MoU) was formally exchanged successful the beingness of Chairman Lavu Rathaiah, Vice-Chancellor P. Nagabhushan, and Advisor M. Malakondaiah, astatine the University field present connected Friday (December 12, 2025). Representing Ipseity Diagnostics, CEO Dr. Sandeep Nadendla and CMO Dr. Kalyan Chakravarthy K. signed the statement with Prof. P.M.V. Rao and Prof. Vijaya Ramu Dirisala of Vignan’s Foundation.
According to the institutions, the collaboration is expected to accelerate efforts to bring molecular subject “from seat to bedside,” offering caller diagnostic solutions for patients suffering from sepsis, drug-resistant and uncontrolled infections, and different captious illnesses. The probe inaugural is besides aimed astatine processing indigenous, affordable technologies tailored to the needs of the Indian healthcare system.
Dr. Kalyan Chakravarthy said the concern positions Andhra Pradesh arsenic an emerging hub for high-end biomedical probe and could payment millions of patients done faster, much accurate, and cost-effective diagnostic tools.
